- Trump administration will bring special ed to HHSInfant mortality rate dips, OTC naloxone options rise, and other health news from Morning RoundsSTAT · 1mo ago↗ source
- STAT+: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approvalThe FDA has reversed its opposition to a closely watched experimental treatment for Huntington’s disease, clearing a path for its maker.STAT · 1mo ago↗ source
- A new Westlake-backed biotech takes aim at migraines<p>Vedana Therapeutics emerged from stealth Wednesday with $46 million to support its mission of developing “anti-PACAP” therapies, an increasingly popular strategy for migraine prevent…BioPharma Dive · 1mo ago↗ source